Cytek Biosciences, Inc. (CTKB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cytek Biosciences, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -9.70x | -140.81x | -101.56x | 533.13x | 727.36x | 128.53x |
| P/B Ratio | 1.89x | 2.14x | 3.14x | 3.23x | 5.39x | -155.66x |
| P/S Ratio | 3.20x | 4.23x | 6.39x | 8.37x | 17.06x | 26.87x |
| Profitability | ||||||
| Gross Margin | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% | 55.7% |
| Operating Margin | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% | 14.7% |
| Net Margin | -33.0% | -3.0% | -6.3% | 1.6% | 2.3% | 20.9% |
| EBITDA Margin | -8.6% | -5.0% | -2.3% | 5.8% | 7.0% | 16.6% |
| Liquidity | ||||||
| Current Ratio | 5.04x | 5.86x | 6.97x | 9.26x | 13.01x | 7.86x |
| Quick Ratio | 4.42x | 5.21x | 5.89x | 8.28x | 12.04x | 6.99x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.04x | 0.04x | 0.04x | 0.00x | -0.17x |
YoY = year-over-year change. Source: FMP..